Status:
COMPLETED
Outcomes in CArdiogenic SHock Patients Treated by MEchanical Circulatory suppoRt devicE : Impact of Shock Team
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Cardiogenic Shock
Short Term Mechanical Circulatory Support
Eligibility:
All Genders
18+ years
Brief Summary
In this before-after monocenter study, the authors teste the hypothesis that the implementation of a dedicated shock team could improve the outcome of patients with refractory cardiogenic shock assist...
Detailed Description
Short Term Mechanical Circulatory Support (STMCS) are the last resort therapeutics when refractory cardiogenic shock occurs. Growing technical possibilities like impella make the right choice at the r...
Eligibility Criteria
Inclusion
- Diagnosis of cardiogenic shock
- \>1 sign of refractory cardiogenic shock : Dobutamine \>10µg/kg/mn, epinephrine\>0.25µg/kg/mn or Milrinone \> 0.5µg/kg/mn ; ScvO2\<55% ; pO2/FiO2\<100
- No major counter indication to short term mechanical circulatory support : SOFA score \> 15, prolonged cardiac arrest, severe chronic disease, direct LVAD implantation or heart transplantation, counter indication for systemic anticoagulation
Exclusion
- Age \< 18years
- Post cardiotomy cardiogenic shock
- Implantation of Impella 2.5 alone
- Implantation of Intra Aortic Balloon Pump alone
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05309980
Start Date
April 1 2021
End Date
April 15 2022
Last Update
April 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bordeaux University Hospital
Pessac, France, 33604